Dupont Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-18,850
| Closed | -$447K | – | 1372 |
|
|
2019
Q4 | $447K | Sell |
18,850
-15,194
| -45% | -$360K | 0.01% | 892 |
|
|
2019
Q3 | $936K | Sell |
34,044
-3,650
| -10% | -$100K | 0.02% | 546 |
|
|
2019
Q2 | $1.25M | Hold |
37,694
| – | – | 0.03% | 484 |
|
|
2019
Q1 | $1.32M | Hold |
37,694
| – | – | 0.03% | 474 |
|
|
2018
Q4 | $1.25M | Buy |
37,694
+7,073
| +23% | +$235K | 0.03% | 474 |
|
|
2018
Q3 | $1.54M | Hold |
30,621
| – | – | 0.03% | 452 |
|
|
2018
Q2 | $1.83M | Hold |
30,621
| – | – | 0.04% | 395 |
|
|
2018
Q1 | $1.4M | Buy |
30,621
+22,295
| +268% | +$1.02M | 0.03% | 418 |
|
|
2017
Q4 | $332K | Hold |
8,326
| – | – | 0.01% | 741 |
|
|
2017
Q3 | $333K | Hold |
8,326
| – | – | 0.01% | 749 |
|
|
2017
Q2 | $359K | Buy |
+8,326
| New | +$359K | 0.01% | 743 |
|
|
2016
Q4 | – | Sell |
-20,027
| Closed | -$495K | – | 867 |
|
|
2016
Q3 | $495K | Sell |
20,027
-61,674
| -75% | -$1.52M | 0.01% | 570 |
|
|
2016
Q2 | $1.66M | Hold |
81,701
| – | – | 0.04% | 331 |
|
|
2016
Q1 | $1.25M | Buy |
81,701
+18,287
| +29% | +$279K | 0.03% | 413 |
|
|
2015
Q4 | $852K | Sell |
63,414
-12,623
| -17% | -$170K | 0.02% | 499 |
|
|
2015
Q3 | $1.07M | Hold |
76,037
| – | – | 0.03% | 444 |
|
|
2015
Q2 | $1.29M | Buy |
76,037
+45,738
| +151% | +$777K | 0.03% | 402 |
|
|
2015
Q1 | $366K | Hold |
30,299
| – | – | 0.01% | 534 |
|
|
2014
Q4 | $251K | Hold |
30,299
| – | – | ﹤0.01% | 584 |
|
|
2014
Q3 | $263K | Sell |
30,299
-1,700
| -5% | -$14.8K | ﹤0.01% | 609 |
|
|
2014
Q2 | $350K | Buy |
31,999
+31,899
| +31,899% | +$349K | 0.01% | 605 |
|
|
2014
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 622 |
|
|
2013
Q4 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 597 |
|